News

Snatch This Bargain Even Cheaper Than Director Thomas Did

NRIM

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 8, Northrim BanCorp Inc's Director, Linda C. Thomas, invested $31,440.00 into 1,200 shares of NRIM, for a cost per share of $

JPMorgan double upgraded a data center stock that struck a deal with Nvidia earlier this year

NVDA, NVDAN, NVDACL, NVD, NVDD, 1NVDA, 4NVDA, 0R1I, 918422, NVDAUS, NVDA0, NVDA1, NVDACL1, NVDACL0

The investment bank double upgraded the artificial intelligence infrastructure stock to overweight from underweight.

SM Energy’s Civitas Merger Is Paying Off, But the Stock’s Run Raises the Bar

SM, FANG, DVN, EOG

The oil patch is enjoying big profits these days, and SM Energy (NYSE: SM) has timed it perfectly. The Denver-based company closed a transformational merger early this year, profits soared in the second quarter, and the stock has doubled since the start of the year. For investor

If You Own This 12.7% Dividend, Sell It Yesterday

PHK

Usually in this space, we dig into 8%+ paying closed-end funds (CEFs) set to hand us strong returns and large income streams.

Bank of America says we are overdue for a stock pullback

BAC, 858388

Stocks have gone too long without a proper shakeup, worries Bank of America.

Can Audience Unlimited Accelerate Trade Desk's Growth Momentum?

TTD, MGNI, PUBM

TTD expands Audience Unlimited, using AI and simpler data pricing to boost advertiser efficiency and support more durable growth.

Microsoft sets limits for future AI models as industry throttles frontier development

MSFT, MSFTN, MSFTCL, MSFTCO, MSFD, AI, MSFTUS, MSFT1, MSFT0, MSFTCL0, MSFTCL1, 4250

Microsoft wants to be seen as a responsible AI entity as it ramps up model development alongside partners Anthropic and OpenAI.

Space startups raise big money in funding blitz as Europe aims to challenge U.S. dominance

European space startups are attracting fresh funding as the region seeks to build its capabilities and narrow a its gap with the U.S.

McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal

MCK

Cardinal Health Earnings: Can Perfection Get Priced In Twice?McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty an

AI stocks tumble on safety warnings. How to proceed — including 2 names on our shopping list

Jim Cramer offers a roadmap to navigate Monday's sell-off in AI stocks.